|
|
|
| home > white papers > Crossing the Blood Brain Barrier (BBB): Which Route to Take? - Aptar Pharma |
|
|
 WHITE PAPERS |
|
Aptar Pharma
|
|
Crossing the Blood Brain Barrier (BBB): Which Route to Take?
|
|
Aptar Pharma recently hosted an expert panel/roundtable on the various
approaches to treating central nervous system (CNS) diseases. This
international scientific forum was held in Paris, France on December
5th, 2014. The roundtable was organized to explore and exchange views on
the challenges, approaches and opportunities that exist with regard to
effectively crossing the blood brain barrier (BBB) and successfully
treating a host of CNS diseases.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Interpack: First full-featured HERMA 500 label applicator
Non-stop high speed
• With motorized winders and a loop unit, the new HERMA 500 applies up to 2,000 labels a minute, synchronized with the product speed.
• For continuous duty, the optional active cooling unit maintains top performance with unrivalled precision and stability
. • HERMA is setting the latest benchmark for applicators as regards performance, connectivity, ease of use and quality.
More info >> |
|
 |
White Papers |
 |
|
PROTEIN:PROTEIN INTERACTION ANALYSIS
IBA GmbH
Groth et al., 2007 and Jasencakova et al., 2010 Protein:protein-interactions (PPI) govern almost all important processes in living organisms. Thus, their rapid and accurate determination and investigation is a major challenge in life sciences. The extremely efficient and fast One-STrEP (Twin-Strep) system is suitable for the isolation of functional protein complexes and subsequent mass spectrometry analysis leads to the identification of protein complex components (Junttila et al., 2005) as it is shown in the following studies.
More info >> |
|
 |
Industry Events |
 |
Formulation and Drug Delivery Series UK
8-9 July 2020, Oxford Global
This event brings together leading formulation, drug delivery and biologics manufacturing experts from around the world across two days. The panel of prominent industry leaders and world-leading scientists will share the latest case studies, innovative developments for novel therapeutic products and strategies for drug development.
More info >> |
|
|
|
